Wheeler John R C, White Bert, Rauscher Simone, Nahra Tammie A, Reiter Kristin L, Curtin Kathleen M, Damberg Cheryl L
University of Michigan School of Public Health, USA.
J Health Care Finance. 2007 Summer;33(4):17-30.
One of the major reasons providers give for not implementing promising quality-enhancing interventions (QEI) is that no "business case" for quality has been made. This article clarifies the concepts of the business case for quality and the related economic case for quality and identifies the perspectives of the various actors in health care financing, production, and consumption decisions. A methodology to evaluate the business case for quality from the perspective of payers and providers is presented. The article then uses implemented QEIs to show how a pay-for-performance (P4P) program can alter the business cases for payers and providers. Specifically, the P4P programs described in this article allow a provider to implement a QEI with the financial alignment of the payer in order to achieve financial and non-financial benefits. In some cases, providers and payers may be able to establish P4P programs providing net benefits for both parties.
医疗服务提供者不实施前景良好的质量提升干预措施(QEI)的一个主要原因是,尚未提出质量方面的“商业案例”。本文阐明了质量商业案例及相关质量经济案例的概念,并确定了医疗保健融资、生产和消费决策中各行为主体的观点。提出了一种从付款人和医疗服务提供者角度评估质量商业案例的方法。然后,本文通过已实施的QEI来说明按绩效付费(P4P)计划如何改变付款人和医疗服务提供者的商业案例。具体而言,本文所述的P4P计划允许医疗服务提供者在付款人的财务支持下实施QEI,以实现财务和非财务效益。在某些情况下,医疗服务提供者和付款人或许能够建立对双方都有净效益的P4P计划。